Construction and validation of a risk prediction model for recurrent pregnancy losses in patients with positive antiphospholipid antibodies
{{output}}
To identify independent risk factors for recurrent pregnancy loss (RPL) among antiphospholipid antibody (aPL)-positive individuals who were either in early pregnancy (≤12 weeks' gestation) or not pregnant, and to develop and validate a risk prediction model ... ...
